Summary
McKesson Corp.'s 10-Q filing from February 1997 provides a snapshot of its financial performance for the period ending June 29, 1996. As a major distributor of pharmaceuticals and health-related products, McKesson's operations are critical to the healthcare supply chain. Investors would be keen to understand the company's revenue generation, profitability trends, and any significant operational changes or challenges during this fiscal period. While the provided text is primarily an index to the filing rather than the financial statements themselves, it indicates an amendment (10-Q/A), suggesting a potential correction or update to previously reported information. Investors should scrutinize any amended filings for clarity on the nature of the amendments and their potential impact on the company's financial health and future outlook.
Key Highlights
- 1The filing is a Quarterly Report Amendment (10-Q/A) for McKesson Corp., indicating a revision to a previous filing.
- 2The period ending date for the report is June 29, 1996.
- 3The filing date is February 12, 1997, suggesting a significant delay between the period end and the filing, or in this case, the amendment filing.
- 4The document is hosted on the SEC's EDGAR system, accessible via a directory listing.
- 5Key financial performance details, such as revenue and net income, would typically be found within the full filing documents (.txt, .html).
- 6The nature of the amendment could relate to accounting adjustments, disclosures, or other material information that required correction or updating.
- 7Investors should pay close attention to the specific reasons for the amendment as detailed within the full 10-Q/A document.